Evidence map›Paper›PMID 40484629›Full record

Trial reportBMJ quality & safety2026

Implementation of a patient-centred complex intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): a mixed-methods process evaluation.

Carmen Corral-Partearroyo, Alba Sánchez-Viñas, María Teresa Peñarrubia-María, Montserrat Gil-Girbau, Ignacio Aznar-Lou, Claudia Palma-Vasquez, Carmen Gallardo-González, María Del Carmen Olmos-Palenzuela, Maria Rubio-Valera

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMJ quality & safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05026775 (Effectiveness and Cost-effectiveness of the Initial Medication Adherence Intervention), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05026775 naunknown statusnot on this map

Effectiveness and Cost-effectiveness of the Initial Medication Adherence Intervention: Cluster-randomized Controlled Trial and Economic Model

TypeinterventionalSponsorFundació Sant Joan de DéuRan2022 to 2023Enrolled4,153ConditionsAdherence, MedicationArmsInitial Medication Adherence (IMA), Usual care
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carmen Corral-PartearroyoHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.ORCID http://orcid.org/0000-0001-9517-4916
Alba Sánchez-ViñasHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.ORCID http://orcid.org/0000-0001-5020-7534
María Teresa Peñarrubia-MaríaHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.
Montserrat Gil-GirbauHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.ORCID http://orcid.org/0000-0002-4396-6492
Ignacio Aznar-LouHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.
Claudia Palma-VasquezHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.ORCID http://orcid.org/0000-0001-8830-1884
Carmen Gallardo-GonzálezHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.ORCID http://orcid.org/0000-0003-0688-1366
María Del Carmen Olmos-PalenzuelaHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain.ORCID http://orcid.org/0000-0003-4078-6717
Maria Rubio-ValeraHealth Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, St Boi de Llobregat, Catalonia, Spain maria.rubio@sjd.es.ORCID http://orcid.org/0000-0003-2856-1697

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe initial medication adherence (IMA) intervention aims to improve adherence to cardiovascular disease (CVD) and diabetes treatments in primary care (PC) through standardised shared decision-making (SDM) and healthcare professional (HCP) collaboration (general practitioners (GPs), nurses and pharmacists). This study assessed the intervention's implementation (strategies, fidelity and integration into routine practice-based on the Normalisation Process Theory), mechanisms of action and the role of context.

methodsThe IMA-cRCT was an effectiveness-implementation cluster-Randomised Controlled Trial involving 24 Spanish PC centres (>300 HCP; >3000 patients) based on real-world evidence. This nested process evaluation used quantitative (monitoring data; HCP questionnaires) and qualitative methods (field diaries; 36 semistructured individual interviews and two focus groups (19 patients, 28 HCPs)). Quantitative data explored implementation and context and were analysed descriptively, while qualitative data examined implementation, mechanisms of action and context and were analysed using framework analysis. Both analyses were integrated for interpretation.

resultsIntervention implementation fidelity (6.5/10) and normalisation into clinical practice (7.6/10) were adequate, particularly regarding SDM and use of decision aids. HCPs recognised the importance of SDM, although some assumed it was already part of routine practice. The anticipated mechanisms of action were moderately supported. HCPs' knowledge and attitudes towards SDM improved as they acknowledged its relevance to practice. Some patients reported participation in decision-making, while others preferred the GP to decide on their behalf. Patients found leaflets helpful for understanding information. Contextual factors influencing the intervention were mainly organisational, such as lack of time and familiarity with SDM.

conclusionsThe interprofessional SDM-based IMA intervention was considered beneficial for patients and HCPs, with adequate implementation fidelity and normalisation into practice. The intervention was important for HCPs, and patients accepted it. However, greater effort is needed to extend SDM throughout healthcare, moving towards patient-centred care. These results have enhanced understanding of SDM interventions and support their refinement for future implementation. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov, NCT05026775.

Indexed as

Cardiovascular DiseasesDiabetes MellitusMedication AdherencePatient-Centered CarePrimary Health CareAdherence InterventionsAgedDecision Making, SharedFemaleFocus GroupsHumansMaleMiddle AgedEvaluation methodologyImplementation sciencePatient-centred carePrimary careShared decision making

Identifiers

PMID40484629
PMCPMC13638341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.